H.C. Wainwright Reiterates Buy Rating on Immix Biopharma, Inc. (IMMX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: IMMX) | Delayed: 8.22 +0.24 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.98 | 52 Week High | $ | |||
| Open | $8.05 | 52 Week Low | $ | |||
| Day High | $8.35 | P/E | N/A | |||
| Day Low | $8.00 | EPS | $ | |||
| Volume | 1,302,420 | |||||
